1. 1) Act on Securing Quality, “Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices. Act No. 145 of August 10, 1960.”: 〈https://www.mhlw.go.jp/web/t_doc?dataId=81004000&dataType=0&pageNo=1〉, cited 31 January, 2024.
2. 2) Japan Pharmaceutical Association. “Yakuzai shiyoukikanchu no kanja follow up no tebiki (Version 1.2).”: 〈https://www.nichiyaku.or.jp/assets/uploads/pharmacy-info/followup_1.2.pdf〉, cited 29 December, 2023.
3. 3) Harigai S., Tanaka R., Sekiya S., Shikamura Y., Jpn. J. Drug Inform., 23, 72–81 (2021).
4. 4) Sekiya S., Suzuki T., Tanaka R., Harigai S., Shimono K., Ohura S., Hashiba H., Shikamura Y., Biol. Pharm. Bull., 45, 1091–1100 (2022).
5. 5) Tanaka R., Suzuki T., Harigai S., Sekiya S., Saitoh A., Kato S., Tanaka T., Shimono K., Shikamura Y., Jpn. J. Clin. Pharmacol. Ther., 55, 11–18 (2024).